Market Research Logo

Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020

Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020

In this report, the biomarkers market is segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, and validation biomarkers. The applications segments included in this report are diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and other applications. The disease indications segments included in this report are cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW).

The growth of this market is mainly driven by increasing healthcare expenditure, increase in R&D spending, increasing utility of biomarkers for diagnostics, increasing number of CROs, the low cost of clinical trials in developing countries, and new initiatives for biomarker research. The high growth potential in emerging markets and the increasing adoption of personalized medicine and companion diagnostics provides new growth opportunities to players in the biomarkers market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global biomarkers market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of the biomarkers market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for important subsegments. It maps the market sizes and growth rates of each segment and identifies segments poised to witness rapid growth. The report includes company profiles and a competitive landscape of the biomarkers market. The company profiles include the financial performances, product portfolios, and developments of each company, whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analyses of industry developments such as acquisitions, agreements, collaborations & partnerships; new product launches; and other developments.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and make important strategic growth decisions.

The report provides insights on the following:
Product Development/Innovation: Product portfolios of the top players in the biomarkers market. Detailed insights on upcoming technologies, R&D activities, and new product launches in the biomarkers market
Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the biomarkers market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various biomarkers across geographies
Market Diversification: Exhaustive information about new products, recent developments, and investments in the biomarkers market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED IN THE REPORT
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • Table BIOMARKERS MARKET SNAPSHOT
  • PREMIUM INSIGHTS
    • LUCRATIVE OPPORTUNITIES IN THE GLOBAL BIOMARKERS MARKET
    • LIFE CYCLE ANALYSIS, BY REGION, 2015
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
      • BY PRODUCT
      • BY TYPE
      • BY APPLICATION
      • BY DISEASE INDICATION
    • MARKET DYNAMICS
      • DRIVERS
        • Table INCREASING HEALTHCARE EXPENDITURE IS PROPELLING THE GROWTH OF BIOMARKERS MARKET
      • RESTRAINTS
        • Table POORLY SUITED REGULATORY AND REIMBURSEMENT SYSTEMS-AN ENTRY BARRIER FOR NEW ENTRANTS
      • OPPORTUNITIES
        • Table LIST OF FDA-APPROVED BIOMARKERS FOR DIFFERENT TYPES OF CANCER
        • Table EMERGING ECONOMIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES
      • CHALLENGES
        • Table PROVING THE CLINICAL VALIDITY & UTILITY OF BIOMARKER-BASED TESTS IS A MAJOR CHALLENGE FOR MARKET PLAYERS
  • BIOMARKERS MARKET, BY PRODUCTS
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY PRODUCT, 2013-2020 ($BILLION)
    • CONSUMABLES
      • Table BIOMARKER CONSUMABLES MARKET, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKER CONSUMABLES MARKET, BY REGION, 2013-2020 ($BILLION)
    • SERVICES
      • Table BIOMARKER SERVICES MARKET, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKER SERVICES MARKET, BY REGION, 2013-2020 ($BILLION)
    • SOFTWARE
      • Table BIOMARKER SOFTWARE MARKET, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKER SOFTWARE MARKET, BY REGION, 2013-2020 ($MILLION)
  • BIOMARKERS MARKET, BY TYPE
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
    • SAFETY BIOMARKERS
      • Table SAFETY BIOMARKERS MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: SAFETY BIOMARKERS MARKET, BY COUNTRY, 2013-2020 ($BILLION)
    • EFFICACY BIOMARKERS
      • Table EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table EFFICACY BIOMARKERS MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: EFFICACY BIOMARKERS MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
      • PREDICTIVE BIOMARKERS
        • Table PREDICTIVE BIOMARKERS MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
        • Table NORTH AMERICA: PREDICTIVE BIOMARKERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
      • SURROGATE BIOMARKERS
        • Table SURROGATE BIOMARKERS MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
        • Table NORTH AMERICA: SURROGATE BIOMARKERS MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
      • PHARMACODYNAMIC BIOMARKERS
        • Table PHARMACODYNAMIC BIOMARKERS MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
        • Table NORTH AMERICA: PHARMACODYNAMIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
      • PROGNOSTIC BIOMARKERS
        • Table PROGNOSTIC BIOMARKERS MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
        • Table NORTH AMERICA: PROGNOSTIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
    • VALIDATION BIOMARKERS
      • Table VALIDATION BIOMARKERS MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: VALIDATION BIOMARKERS MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
  • BIOMARKERS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY APPLICATION, 2013-2020 ($BILLION)
    • DIAGNOSTICS DEVELOPMENT
      • Table DIAGNOSTICS DEVELOPMENT MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: DIAGNOSTICS DEVELOPMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
    • DRUG DISCOVERY AND DEVELOPMENT
      • Table DRUG DISCOVERY AND DEVELOPMENT MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
    • PERSONALIZED MEDICINE
      • Table PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
    • DISEASE RISK ASSESSMENT
      • Table DISEASE RISK ASSESSMENT MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: DISEASE RISK ASSESSMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
    • OTHER APPLICATIONS
      • Table BIOMARKERS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2013-2020 ($BILLION)
  • BIOMARKERS MARKET, BY DISEASE INDICATION
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2013-2020 ($BILLION)
    • CANCER
      • Table KEY CANCER BIOMARKERS IN CLINICAL USE
      • Table ASIA TO BE THE FASTEST-GROWING REGIONAL SEGMENT FOR THE CANCER DISEASE INDICATION SEGMENT
      • Table BIOMARKERS MARKET SIZE FOR CANCER, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR CANCER, BY REGION, 2013-2020 ($BILLION)
    • CARDIOVASCULAR DISORDERS
      • Table CARDIOVASCULAR DISORDER BIOMARKERS
      • Table BIOMARKERS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY REGION, 2013-2020 ($BILLION)
    • NEUROLOGICAL DISORDERS
      • Table BIOMARKERS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY REGION, 2013-2020 ($BILLION)
    • IMMUNOLOGICAL DISORDERS
      • Table BIOMARKERS FOR IMMUNOLOGICAL DISEASES
      • Table BIOMARKERS MARKET SIZE FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2013-2020 ($BILLION)
    • OTHER DISEASES
      • Table BIOMARKERS FOR RENAL DISORDERS
      • Table BIOMARKERS MARKET SIZE FOR OTHER DISEASE INDICATIONS, BY REGION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR OTHER DISEASE INDICATIONS, BY REGION, 2013-2020 ($BILLION)
  • BIOMARKERS MARKET, BY REGION
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY REGION, 2013-2020 ($BILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY COUNTRY, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY PRODUCT, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY APPLICATION, 2013-2020 ($BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2013-2020 ($BILLION)
      • U.S.
        • Table U.S.: BIOMARKERS MARKET SIZE, BY PRODUCT, 2013-2020 ($BILLION)
        • Table U.S.: BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
        • Table U.S.: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
        • Table U.S.: BIOMARKERS MARKET SIZE, BY APPLICATION, 2013-2020 ($BILLION)
        • Table U.S.: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2013-2020 ($BILLION)
      • CANADA
        • Table CANADA: BIOMARKERS MARKET SIZE, BY PRODUCT, 2013-2020 ($BILLION)
        • Table CANADA: BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
        • Table CANADA: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
        • Table CANADA: BIOMARKERS MARKET SIZE, BY APPLICATION, 2013-2020 ($BILLION)
        • Table CANADA: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2013-2020 ($BILLION)
    • EUROPE
      • Table EUROPE: BIOMARKERS MARKET SIZE, BY PRODUCT, 2013-2020 ($BILLION)
      • Table EUROPE: BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table EUROPE: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table EUROPE: BIOMARKERS MARKET SIZE, BY APPLICATION, 2013-2020 ($BILLION)
      • Table EUROPE: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2013-2020 ($BILLION)
    • ASIA
      • Table ASIA: BIOMARKERS MARKET SIZE, BY PRODUCT, 2013-2020 ($BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table ASIA: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE, BY APPLICATION, 2013-2020 ($BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2013-2020 ($BILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: BIOMARKERS MARKET SIZE, BY PRODUCT, 2013-2020 ($BILLION)
      • Table ROW: BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table ROW: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2013-2020 ($BILLION)
      • Table ROW: BIOMARKERS MARKET SIZE, BY APPLICATION, 2013-2020 ($BILLION)
      • Table ROW: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2013-2020 ($BILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • STRATEGIC OVERVIEW
    • MARKET SHARE ANALYSIS, BIOMARKERS MARKET
    • COMPETITIVE SITUATION AND TRENDS
      • Table MARKET DEVELOPMENTS BETWEEN JANUARY 2012 AND MAY 2015
      • ACQUISITIONS
        • Table ACQUISITION, 2012-2015
      • AGREEMENTS, COLLABORATIONS, EXPANSION, JOINT VENTURES, AND PARTNERSHIPS
        • Table AGREEMENT, COLLABORATIONS, EXPANSION, JOINT VENTURES AND PARTNERSHIPS, 2012-2015
      • NEW PRODUCT AND SERVICE LAUNCHES
        • Table NEW PRODUCT AND SERVICE LAUNCHES, 2012-2015
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2012-2015
  • COMPANY PROFILES
    • INTRODUCTION
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • PERKINELMER, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERCK & CO, INC.
      • BUSINESS OVERVIEW
      • PRODUCT & SERVICES
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ENZO BIOCHEM, INC.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • EKF DIAGNOSTICS HOLDINGS, INC.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MESO SCALE DIAGNOSTICS, LLC.
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES
      • RECENT DEVELOPMENTS
    • SINGULEX, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES
      • RECENT DEVELOPMENTS
    • BIOSIMS TECHNOLOGIES
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
    • CISBIO BIOASSAYS
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES
      • RECENT DEVELOPMENTS
    • SIGNOSIS, INC.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report